Chapter
The Potential of Psilocybin as a Medicine
04:17 - 10:31 (06:14)
Recent studies indicate that psilocybin may be approved as a Schedule Four medicine due to its low abuse liability and potential benefits for treating anxiety and depression in just a single high-dose session.
Clips
Researchers reviewed the scientific literature and concluded that psilocybin belongs in schedule four, based on its low risk of abuse and harm.
04:17 - 10:31 (06:14)
Psilocybin
Summary
Researchers reviewed the scientific literature and concluded that psilocybin belongs in schedule four, based on its low risk of abuse and harm. Additionally, a single high-dose session of psilocybin has been found to lead to sustained reductions in depression and anxiety six months after treatment.